08:00 , Feb 11, 2013 |  BC Week In Review  |  Clinical News

DSP-6952: Phase II started

In its 3Q12 earnings ending Dec. 31, 2012, Dainippon said it began a double-blind, placebo-controlled, Japanese Phase II trial to evaluate oral DSP-6952 in about 165 patients. Dainippon Sumitomo Pharma Co. Ltd. (Tokyo:4506; Osaka:4506), Osaka,...